Literature DB >> 15878436

Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia.

Gang Liu1, Deborah F Talkington, Barry S Fields, Orin S Levine, Yonghong Yang, Maria Lucia C Tondella.   

Abstract

Eighty-five cases community-acquired pneumonia (CAP) in children 5 years or younger, confirmed by chest X-ray, and 185 age-matched control patients with diarrhea or dermatitis from the Outpatient Department at Beijing Children's Hospital were enrolled into this study. Nasopharyngeal swab specimens were obtained from all subjects. Real-time PCR-based fluorescence assays were performed for Chlamydia pneumoniae and Mycoplasma pneumoniae. A nested PCR was also run for C. pneumoniae for comparison of assays. C. pneumoniae was found in 3 (3.5%) of CAP cases and in 4 (2.1%) of controls (P = 0.51). M. pneumoniae was found in 6 (7.1%) of CAP cases and in none of the controls (P = 0.001). The agreement rate of the 2 applied PCR methods used for C. pneumoniae detection was 98.5%. Our study demonstrates that M. pneumoniae may play a significant role in CAP affecting children up to 5 years in China, whereas C. pneumoniae in nasopharyngeal specimens was not associated with CAP in this age group.

Entities:  

Mesh:

Year:  2005        PMID: 15878436     DOI: 10.1016/j.diagmicrobio.2005.01.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

1.  Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach.

Authors:  Roger Dumke; Nicol Schurwanz; Matthias Lenz; Markus Schuppler; Christian Lück; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

2.  Comparison of commercial and in-house real-time PCR assays used for detection of Mycoplasma pneumoniae.

Authors:  Roger Dumke; Enno Jacobs
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

3.  Study of Two Separate Types of Macrolide-Resistant Mycoplasma pneumoniae Outbreaks.

Authors:  Yingshuo Wang; Qian Ye; Dehua Yang; Zhimin Ni; Zhimin Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  Designing of an epitope-based peptide vaccine against walking pneumonia: an immunoinformatics approach.

Authors:  P Ambili Unni; A M Mohamed Thoufic Ali; Madhusmita Rout; A Thabitha; S Vino; S Sajitha Lulu
Journal:  Mol Biol Rep       Date:  2018-11-21       Impact factor: 2.316

5.  Epidemiology and clinical features of segmental/lobar pattern Mycoplasma pneumoniae pneumonia: A ten-year retrospective clinical study.

Authors:  Jian Gao; Baozhu Yue; Haitao Li; Rong Chen; Chunlian Wu; Mili Xiao
Journal:  Exp Ther Med       Date:  2015-10-19       Impact factor: 2.447

6.  The clinical characteristics of corticosteroid-resistant refractory Mycoplasma Pneumoniae pneumonia in children.

Authors:  Yongdong Yan; Yuzhen Wei; Wujun Jiang; Chuangli Hao
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

Review 7.  Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods.

Authors:  K Loens; H Goossens; M Ieven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-06       Impact factor: 3.267

Review 8.  Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review.

Authors:  Rodrigo DeAntonio; Juan-Pablo Yarzabal; James Philip Cruz; Johannes E Schmidt; Jos Kleijnen
Journal:  Hum Vaccin Immunother       Date:  2016-06-07       Impact factor: 3.452

9.  Current Research of Chlamydial Infection Diseases in China.

Authors:  Xue Li; Qing-Feng Liang; Guan-Yu Su; Li-Yuan Wu; Xin-Xin Lu; Ning-Li Wang
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

10.  A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia.

Authors:  Li-Ping Han; Han-Yan Xiao; Li-Li Fang
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.